Oy Juvantia Pharma Ltd.
Records under this name other than patents Oy Juvantia Pharma Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Oy Juvantia Pharma Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,653,122 | Oromucosal formulation and process for preparing the same Formerly held Lapsed on the fee record Ended Feb 18, 2022 · From the USPTO record | Lapsed on the fee record | Ended Feb 18, 2022 | From the USPTO record |
| US 7,223,871 | Process for preparing substituted imidazole derivatives and intermediates used in the process Lapsed on the fee record Ended May 29, 2015 · From the USPTO record | Lapsed on the fee record | Ended May 29, 2015 | From the USPTO record |
| US 7,741,362 | Somatostatin receptor 1 and/or 4 selective agonists and antagonists Formerly held Lapsed on the fee record Ended Jun 22, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jun 22, 2014 | From the USPTO record |
| US 6,521,632 | Method for the treatment or prevention of a disease mediated by the alpha-2B-adrenoceptor Lapsed on the fee record Ended Feb 18, 2011 · From the USPTO record | Lapsed on the fee record | Ended Feb 18, 2011 | From the USPTO record |
| US 6,124,256 | Method for the prevention of a patient's fibroproliferative vasculopathy Lapsed on the fee record Ended Sep 26, 2008 · From the USPTO record | Lapsed on the fee record | Ended Sep 26, 2008 | From the USPTO record |
| US 6,767,909 | Compounds useful for treatment or prevention of disease mediated by alpha-2B-adrenoceptor Lapsed on the fee record Ended Jul 27, 2008 · From the USPTO record | Lapsed on the fee record | Ended Jul 27, 2008 | From the USPTO record |
| US 6,696,556 | DNA molecule encoding a variant &agr;2B-adrenoceptor protein, and uses thereof Lapsed on the fee record Ended Feb 24, 2008 · From the USPTO record | Lapsed on the fee record | Ended Feb 24, 2008 | From the USPTO record |
| US 6,593,324 | Dervatives of quinoline as alpha-2 antagonists Lapsed on the fee record Ended Jul 15, 2007 · From the USPTO record | Lapsed on the fee record | Ended Jul 15, 2007 | From the USPTO record |
| US 5,902,807 | Method for the treatment of mental illness in mammals and a composition therefor Formerly held Term ended Term ended no later than May 11, 2019 · Low confidence | Term ended | Term ended no later than May 11, 2019 | Low confidence |